Trial Profile
Multinational Abluminal Sirolimus Coated BiO-Engineered StenT - The MASCOT Post Marketing Registry
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Jan 2022
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Coronary artery restenosis; Myocardial infarction
- Focus Therapeutic Use
- Acronyms MASCOT
- Sponsors OrbusNeich
- 24 Apr 2020 Results published in the American Journal of Cardiology
- 29 Aug 2018 Results presented at the ESC Congress 2018: Annual Congress of the European Society of Cardiology
- 02 Jan 2018 New trial record